Home/Sedia Biosciences/Ritesh Jaiswal

RJ

Ritesh Jaiswal

Chief Business Officer

Sedia Biosciences

Therapeutic Areas

Infectious Disease HIV/AIDS

Sedia Biosciences Pipeline

Drug	Indication	Phase
HIV Recency Assays	HIV Infection Recency (Incidence Monitoring)	Commercial
Rapid POC Assays	Infectious Diseases & Other Markers	Development
Specimen Collection Devices	Specimen Stabilization & Transport	Development/Commercial

Leadership Team at Sedia Biosciences

Roger I. Gale, M.E.

Chief Executive Officer, President & Co-Founder

Ronald Mink, Ph.D.

Advisor, Science and Technology & Co-Founder

Alan Lofquist, Ph.D.

Vice President, R&D

View full Sedia Biosciences profile